In the original publication [1], Figure 1 was created by an artificial intelligence (AI) tool but without disclosing the information in the Material and Methods section. The corrected Figure 1 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 1.
Examples of current drug delivery strategies for the treatment of NSCLC.
Reference
- Al Khatib, A.O.; El-Tanani, M.; Al-Obaidi, H. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2023, 15, 2777. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).